Baseline (18)F-FDG PET/CT radiomics in classical Hodgkin’s lymphoma: The predictive role of the largest and the hottest lesions Journal Article


Authors: Triumbari, E. K. A.; Gatta, R.; Maiolo, E.; De Summa, M.; Boldrini, L.; Mayerhoefer, M. E.; Hohaus, S.; Nardo, L.; Morland, D.; Annunziata, S.
Article Title: Baseline (18)F-FDG PET/CT radiomics in classical Hodgkin’s lymphoma: The predictive role of the largest and the hottest lesions
Abstract: This study investigated the predictive role of baseline 18F-FDG PET/CT (bPET/CT) radiomics from two distinct target lesions in patients with classical Hodgkin’s lymphoma (cHL). cHL patients examined with bPET/CT and interim PET/CT between 2010 and 2019 were retrospectively included. Two bPET/CT target lesions were selected for radiomic feature extraction: Lesion_A, with the largest axial diameter, and Lesion_B, with the highest SUVmax. Deauville score at interim PET/CT (DS) and 24-month progression-free-survival (PFS) were recorded. Mann–Whitney test identified the most promising image features (p < 0.05) from both lesions with regards to DS and PFS; all possible radiomic bivariate models were then built through a logistic regression analysis and trained/tested with a cross-fold validation test. The best bivariate models were selected based on their mean area under curve (mAUC). A total of 227 cHL patients were included. The best models for DS prediction had 0.78 ± 0.05 maximum mAUC, with a predominant contribution of Lesion_A features to the combinations. The best models for 24-month PFS prediction reached 0.74 ± 0.12 mAUC and mainly depended on Lesion_B features. bFDG-PET/CT radiomic features from the largest and hottest lesions in patients with cHL may provide relevant information in terms of early response-to-treatment and prognosis, thus representing an earlier and stronger decision-making support for therapeutic strategies. External validations of the proposed model are planned. © 2023 by the authors.
Keywords: adult; cancer survival; controlled study; treatment response; major clinical study; area under the curve; cancer patient; follow up; progression free survival; retrospective study; prediction; histology; fluorodeoxyglucose f 18; informed consent; decision making; rank sum test; classical hodgkin lymphoma; image segmentation; 18f-fdg pet/ct; feature extraction; metabolic tumor volume; maximum standardized uptake value; cancer prognosis; prognosis; human; male; female; article; radiomics; positron emission tomography-computed tomography; therapy escalation; classical hodgkin’s lymphoma
Journal Title: Diagnostics
Volume: 13
Issue: 8
ISSN: 2075-4418
Publisher: MDPI  
Date Published: 2023-04-02
Start Page: 1391
Language: English
DOI: 10.3390/diagnostics13081391
PROVIDER: scopus
PMCID: PMC10137254
PUBMED: 37189492
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors